Connect with KBI at PEGS to find a direct path from complex protein engineering to scalable manufacturing. By leveraging Selexis® SUREtechnology™ and deep analytical expertise, KBI will help partners overcome developability hurdles for next-generation modalities and multispecifics. Meeting with KBI at the summit will offer an ideal way to explore integrated cell line development and clinical production strategies designed to accelerate program paths to the clinic.
Schedule a meeting >>
Meet with KBI Biopharma:
KBI Biopharma is a leading global contract development and manufacturing organization (CDMO) providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. With each of our 1400+ client partners, we work closely to personalize and accelerate drug development programs. Built upon a foundation of world-class analytics capabilities and extensive scientific and technical expertise, we deliver robust process development and clinical and commercial cGMP manufacturing services for mammalian and microbial programs. Recognized for quality manufacturing, we help clients advance drug candidates into the clinic and beyond.
Learn more about KBI Biopharma >>
The 2026 PEGS Boston Summit stands as the premier global forum for biologics and protein engineering. Now in its 22nd year, the summit serves as a critical nexus for over 2,500 industry leaders and academic researchers to explore the transition of biotherapeutics from discovery to the clinic. The 2026 program is anchored by high-growth streams including Multispecific Antibodies, AI/ML-driven Biologics Research, and Next-Generation Immunotherapies, with a brand-new dedicated focus on the engineering and optimization of Emerging Peptide Therapeutics. Attendees can expect a rigorous agenda featuring over 350 presentations, interactive training seminars, and a vibrant exhibit hall showcasing the latest in laboratory automation and analytical tools.